MARY GLENDA BRITANICO: Open Payments
NPI 1326414400 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 26 payments from 8 companies in 2025. Trend: 2023 $94 · 2024 $89 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 5 | $161 |
| AstraZeneca Pharmaceuticals LP | 9 | $141 |
| Amgen Inc. | 5 | $78 |
| Gilead Sciences, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: Leqembi, AIRSUPRA, OTEZLA, MOUNJARO, AJOVY, Yeztugo, Veozah, BREZTRI.
Industry payments across AZ — which companies pay providers there.
